An anonymous donor has put forth $3.58 million to research a deadly disease associated with asbestos exposure.
According to The Associated Press, the funds will help University of Hawaii Cancer Center officials investigate the causes of mesothelioma. It is the second largest donation in the facility's history.
Thecontribution
Read the full story
A clinical trial sponsored by the National Cancer Institute is testing an experimental drug they hope will stop the growth of cancer cells in patients with mesothelioma.
The study, which is being conducted at the National Institutes of Health Clinical Center in Bethesda, Maryland, is in its second phase.Ongoing
Read the full story
A new Medicare pilot program will provide healthcare assistance to Libby, Montana area residents affected by asbestos-related diseases starting July 1.
KPAX-TV, the CBS affiliate in Missoula, Montana, reported that about 1,500 people who use the Center for Asbestos Related Diseases (CARD) Clinic in Libby will qualify for thelong-term
Read the full story
A new study reveals that a specialized combination therapy may help patients suffering from pleural mesothelioma.
The report, which appears in the journal Annals of Thoracic Surgery, was conducted by researchers from the University of Pennsylvania. The team concluded that individuals with mesothelioma, which is caused by exposure toasbestos,
Read the full story
Patients who have either pleural or peritoneal mesothelioma, an asbesto-linked rare form of cancer, are eligible for ongoing recruitment in a Phase II study at Columbia University Medical Center.
The two-drug chemotherapy treatment used during the clinical trial consists of four treatments with the drug Velcade (bortezomib) and two treatments withEloxatin
Read the full story